Alexander Kristen 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+2,700→ 33,050 total - Exercise/Conversion
Common Stock
2024-02-28+15,927→ 59,593 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−2,700→ 0 total→ Common Stock (2,700 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−10,616→ 10,617 total→ Common Stock (10,616 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−15,927→ 31,853 total→ Common Stock (15,927 underlying) - Exercise/Conversion
Common Stock
2024-02-28+10,616→ 43,666 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−11,793$30,898→ 47,800 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.